{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.ai-analytics.org/api/v1/entity/EW/timeline","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://api.ai-analytics.org/license","usage_info":"https://api.ai-analytics.org/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-09-22T11:58:59.115Z","methodology_url":"https://api.ai-analytics.org/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":175,"canonical_name":"Edwards Lifesciences Corp","cik":"0001099800","uei":null,"lei":null,"duns":null,"ticker":"EW"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","open.payments","dol.form5500","hud.housing","irs.bmf"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":103,"clinical":9},"count":100,"timeline":[{"ts":"2026-09-11","kind":"sec.insider.s","reporter":"Lippis Daniel J.","title":"CVP, TAVR","shares":619,"price_per_share":87.51,"usd_value":54169,"security_title":"Common Stock","importance":35.05416869},{"ts":"2026-09-11","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-09-11","url_slug":"/sec/cik-0001099800/4/0001225208-26-007774","accession_number":"0001225208-26-007774","importance":30},{"ts":"2026-09-11","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-09-11","url_slug":"/sec/cik-0001099800/4/0001225208-26-007775","accession_number":"0001225208-26-007775","importance":30},{"ts":"2026-09-11","kind":"sec.insider.m","reporter":"Lippis Daniel J.","title":"CVP, TAVR","shares":619,"price_per_share":72.68,"usd_value":44989,"security_title":"Common Stock","importance":15.04498892},{"ts":"2026-09-11","kind":"sec.insider.f","reporter":"Chopra Daveen","title":"CVP, TMTT, Surgical & IHFM","shares":398,"price_per_share":86.77,"usd_value":34534,"security_title":"Common Stock","importance":15.03453446},{"ts":"2026-08-11","kind":"sec.form144","reporter":"Lippis Daniel J.","title":"Officer","shares":1857,"usd_value":170900,"security_title":"Common","approx_sale_date":"2026-08-11","accession_number":"0001921094-26-000827","importance":40.03418},{"ts":"2026-08-11","kind":"sec.insider.s","reporter":"Lippis Daniel J.","title":"CVP, TAVR","shares":619,"price_per_share":92.03,"usd_value":56967,"security_title":"Common Stock","importance":35.05696657},{"ts":"2026-08-11","kind":"sec.filing","form_type":"144","title":"144 — Edwards Lifesciences Corp — 2026-08-11","url_slug":"/sec/cik-0001099800/144/0001921094-26-000827","accession_number":"0001921094-26-000827","importance":30},{"ts":"2026-08-11","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-08-11","url_slug":"/sec/cik-0001099800/4/0001225208-26-007065","accession_number":"0001225208-26-007065","importance":30},{"ts":"2026-08-11","kind":"sec.insider.m","reporter":"Lippis Daniel J.","title":"CVP, TAVR","shares":619,"price_per_share":72.68,"usd_value":44989,"security_title":"Common Stock","importance":15.04498892},{"ts":"2026-07-13","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-07-13","url_slug":"/sec/cik-0001099800/4/0001225208-26-006591","accession_number":"0001225208-26-006591","importance":30},{"ts":"2026-07-11","kind":"sec.insider.f","reporter":"Bruls Annette","title":"CVP, EMEACLA","shares":109,"price_per_share":92.21,"usd_value":10051,"security_title":"Common Stock","importance":15.01005089},{"ts":"2026-07-07","kind":"sec.insider.f","reporter":"Lippis Daniel J.","title":"CVP, TAVR","shares":377,"price_per_share":95.18,"usd_value":35883,"security_title":"Common Stock","importance":15.03588286},{"ts":"2026-06-30","kind":"sec.insider.s","reporter":"Lippis Daniel J.","title":"CVP, TAVR","shares":619,"price_per_share":91.4002,"usd_value":56577,"security_title":"Common Stock","importance":35.0565767238},{"ts":"2026-06-30","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-06-30","url_slug":"/sec/cik-0001099800/4/0001225208-26-006263","accession_number":"0001225208-26-006263","importance":30},{"ts":"2026-06-30","kind":"sec.insider.m","reporter":"Lippis Daniel J.","title":"CVP, TAVR","shares":619,"price_per_share":72.68,"usd_value":44989,"security_title":"Common Stock","importance":15.04498892},{"ts":"2026-06-17","kind":"sec.insider.s","reporter":"Zovighian Bernard J","title":"CEO","shares":523,"price_per_share":87.92,"usd_value":45982,"security_title":"Common Stock","importance":35.04598216},{"ts":"2026-06-12","kind":"sec.filing","form_type":"11-K","title":"11-K — Edwards Lifesciences Corp — 2026-06-12","url_slug":"/sec/cik-0001099800/11-k/0001099800-26-000035","accession_number":"0001099800-26-000035","importance":30},{"ts":"2026-06-12","kind":"sec.filing","form_type":"11-K","title":"11-K — Edwards Lifesciences Corp — 2026-06-12","url_slug":"/sec/cik-0001099800/11-k/0001099800-26-000036","accession_number":"0001099800-26-000036","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"3","title":"3 — Edwards Lifesciences Corp — 2026-06-01","url_slug":"/sec/cik-0001099800/3/0001225208-26-005669","accession_number":"0001225208-26-005669","importance":30},{"ts":"2026-05-18","kind":"sec.insider.s","reporter":"Lippis Daniel J.","title":"CVP, TAVR","shares":620,"price_per_share":81.14,"usd_value":50307,"security_title":"Common Stock","importance":35.0503068},{"ts":"2026-05-18","kind":"sec.filing","form_type":"144","title":"144 — Edwards Lifesciences Corp — 2026-05-18","url_slug":"/sec/cik-0001099800/144/0001921094-26-000508","accession_number":"0001921094-26-000508","importance":30},{"ts":"2026-05-18","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-05-18","url_slug":"/sec/cik-0001099800/4/0001225208-26-005463","accession_number":"0001225208-26-005463","importance":30},{"ts":"2026-05-18","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-05-18","url_slug":"/sec/cik-0001099800/4/0001225208-26-005464","accession_number":"0001225208-26-005464","importance":30},{"ts":"2026-05-18","kind":"sec.insider.m","reporter":"Lippis Daniel J.","title":"CVP, TAVR","shares":620,"price_per_share":72.68,"usd_value":45062,"security_title":"Common Stock","importance":15.0450616},{"ts":"2026-05-15","kind":"sec.insider.s","reporter":"BOBO DONALD E JR","title":"CVP,Strategy/Corp Development","shares":9968,"price_per_share":82.0732,"usd_value":818106,"security_title":"Common Stock","importance":35.8181056576},{"ts":"2026-05-15","kind":"sec.insider.s","reporter":"BOBO DONALD E JR","title":"CVP,Strategy/Corp Development","shares":8000,"price_per_share":81.8216,"usd_value":654573,"security_title":"Common Stock","importance":35.6545728},{"ts":"2026-05-15","kind":"sec.filing","form_type":"144","title":"144 — Edwards Lifesciences Corp — 2026-05-15","url_slug":"/sec/cik-0001099800/144/0001921094-26-000485","accession_number":"0001921094-26-000485","importance":30},{"ts":"2026-05-12","kind":"sec.form144","reporter":"Zovighian Bernard J","title":"Officer, Director","shares":36874,"usd_value":2873775,"security_title":"Common","approx_sale_date":"2026-05-12","accession_number":"0001921094-26-000459","importance":40.574755},{"ts":"2026-05-12","kind":"sec.insider.s","reporter":"Zovighian Bernard J","title":"CEO","shares":35506,"price_per_share":77.9238,"usd_value":2766762,"security_title":"Common Stock","importance":37.7667624428},{"ts":"2026-05-12","kind":"sec.insider.s","reporter":"Zovighian Bernard J","title":"CEO","shares":845,"price_per_share":78.4027,"usd_value":66250,"security_title":"Common Stock","importance":35.0662502815},{"ts":"2026-05-12","kind":"sec.filing","form_type":"144","title":"144 — Edwards Lifesciences Corp — 2026-05-12","url_slug":"/sec/cik-0001099800/144/0001921094-26-000459","accession_number":"0001921094-26-000459","importance":30},{"ts":"2026-05-12","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-05-12","url_slug":"/sec/cik-0001099800/4/0001225208-26-005172","accession_number":"0001225208-26-005172","importance":30},{"ts":"2026-05-12","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-05-12","url_slug":"/sec/cik-0001099800/4/0001225208-26-005170","accession_number":"0001225208-26-005170","importance":30},{"ts":"2026-05-12","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-05-12","url_slug":"/sec/cik-0001099800/4/0001225208-26-005171","accession_number":"0001225208-26-005171","importance":30},{"ts":"2026-05-12","kind":"sec.insider.g","reporter":"Zovighian Bernard J","title":"CEO","shares":26640,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-12","kind":"sec.insider.g","reporter":"Zovighian Bernard J","title":"CEO","shares":26640,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-11","kind":"sec.insider.s","reporter":"Markowitz Wayne","title":"CVP, JAPAC","shares":593,"price_per_share":79.73,"usd_value":47280,"security_title":"Common Stock","importance":35.04727989},{"ts":"2026-05-11","kind":"sec.filing","form_type":"144","title":"144 — Edwards Lifesciences Corp — 2026-05-11","url_slug":"/sec/cik-0001099800/144/0001921094-26-000453","accession_number":"0001921094-26-000453","importance":30},{"ts":"2026-05-11","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-05-11","url_slug":"/sec/cik-0001099800/4/0001225208-26-005130","accession_number":"0001225208-26-005130","importance":30},{"ts":"2026-05-11","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-05-11","url_slug":"/sec/cik-0001099800/4/0001225208-26-005131","accession_number":"0001225208-26-005131","importance":30},{"ts":"2026-05-11","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-05-11","url_slug":"/sec/cik-0001099800/4/0001225208-26-005132","accession_number":"0001225208-26-005132","importance":30},{"ts":"2026-05-11","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-05-11","url_slug":"/sec/cik-0001099800/4/0001225208-26-005133","accession_number":"0001225208-26-005133","importance":30},{"ts":"2026-05-11","kind":"sec.insider.f","reporter":"Zovighian Bernard J","title":"CEO","shares":26198,"price_per_share":79.96,"usd_value":2094792,"security_title":"Common Stock","importance":17.09479208},{"ts":"2026-05-11","kind":"sec.insider.f","reporter":"Ullem Scott B.","title":"CVP, Chief Financial Officer","shares":11004,"price_per_share":79.96,"usd_value":879880,"security_title":"Common Stock","importance":15.87987984},{"ts":"2026-05-11","kind":"sec.insider.f","reporter":"Chopra Daveen","title":"CVP, TMTT & Surgical","shares":7538,"price_per_share":79.96,"usd_value":602738,"security_title":"Common Stock","importance":15.60273848},{"ts":"2026-05-11","kind":"sec.insider.f","reporter":"BOBO DONALD E JR","title":"CVP,Strategy/Corp Development","shares":7469,"price_per_share":79.96,"usd_value":597221,"security_title":"Common Stock","importance":15.59722124},{"ts":"2026-05-11","kind":"sec.insider.f","reporter":"Lippis Daniel J.","title":"CVP, TAVR","shares":362,"price_per_share":79.96,"usd_value":28946,"security_title":"Common Stock","importance":15.02894552},{"ts":"2026-05-11","kind":"sec.insider.g","reporter":"Zovighian Bernard J","title":"CEO","shares":5489,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-11","kind":"sec.insider.g","reporter":"Zovighian Bernard J","title":"CEO","shares":5489,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-11","kind":"sec.insider.m","reporter":"Ullem Scott B.","title":"CVP, Chief Financial Officer","shares":19830,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-11","kind":"sec.insider.m","reporter":"Zovighian Bernard J","title":"CEO","shares":47207,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-11","kind":"sec.insider.m","reporter":"Chopra Daveen","title":"CVP, TMTT & Surgical","shares":13583,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-11","kind":"sec.insider.m","reporter":"BOBO DONALD E JR","title":"CVP,Strategy/Corp Development","shares":13457,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-08","kind":"sec.filing","form_type":"8-K","title":"8-K — Edwards Lifesciences Corp — 2026-05-08","url_slug":"/sec/cik-0001099800/8-k/0001099800-26-000028","accession_number":"0001099800-26-000028","importance":35},{"ts":"2026-05-08","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-05-08","url_slug":"/sec/cik-0001099800/4/0001225208-26-005042","accession_number":"0001225208-26-005042","importance":30},{"ts":"2026-05-08","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-05-08","url_slug":"/sec/cik-0001099800/4/0001225208-26-005043","accession_number":"0001225208-26-005043","importance":30},{"ts":"2026-05-08","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-05-08","url_slug":"/sec/cik-0001099800/4/0001225208-26-005044","accession_number":"0001225208-26-005044","importance":30},{"ts":"2026-05-08","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-05-08","url_slug":"/sec/cik-0001099800/4/0001225208-26-005045","accession_number":"0001225208-26-005045","importance":30},{"ts":"2026-05-08","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-05-08","url_slug":"/sec/cik-0001099800/4/0001225208-26-005046","accession_number":"0001225208-26-005046","importance":30},{"ts":"2026-05-08","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-05-08","url_slug":"/sec/cik-0001099800/4/0001225208-26-005047","accession_number":"0001225208-26-005047","importance":30},{"ts":"2026-05-08","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-05-08","url_slug":"/sec/cik-0001099800/4/0001225208-26-005048","accession_number":"0001225208-26-005048","importance":30},{"ts":"2026-05-08","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-05-08","url_slug":"/sec/cik-0001099800/4/0001225208-26-005049","accession_number":"0001225208-26-005049","importance":30},{"ts":"2026-05-08","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-05-08","url_slug":"/sec/cik-0001099800/4/0001225208-26-005050","accession_number":"0001225208-26-005050","importance":30},{"ts":"2026-05-08","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-05-08","url_slug":"/sec/cik-0001099800/4/0001225208-26-005051","accession_number":"0001225208-26-005051","importance":30},{"ts":"2026-05-08","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-05-08","url_slug":"/sec/cik-0001099800/4/0001225208-26-005052","accession_number":"0001225208-26-005052","importance":30},{"ts":"2026-05-08","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-05-08","url_slug":"/sec/cik-0001099800/4/0001225208-26-005053","accession_number":"0001225208-26-005053","importance":30},{"ts":"2026-05-08","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-05-08","url_slug":"/sec/cik-0001099800/4/0001225208-26-005054","accession_number":"0001225208-26-005054","importance":30},{"ts":"2026-05-08","kind":"sec.filing","form_type":"4","title":"4 — Edwards Lifesciences Corp — 2026-05-08","url_slug":"/sec/cik-0001099800/4/0001225208-26-005055","accession_number":"0001225208-26-005055","importance":30},{"ts":"2026-05-08","kind":"clinical.trial","reporter":"Edwards Lifesciences","title":"Clinical Study of Edwards Cardioband FIT Valve Repair System","security_title":"NA","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT03382457","excerpt":"[\"Tricuspid Regurgitation\"]","importance":25},{"ts":"2026-05-08","kind":"clinical.trial","reporter":"Edwards Lifesciences","title":"2019-06 TRISCEND Study","security_title":"NA","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT04221490","excerpt":"[\"Tricuspid Valve Regurgitation\",\"Heart Valve Diseases\",\"Cardiovascular Diseases\"]","importance":25},{"ts":"2026-05-08","kind":"clinical.trial","reporter":"Edwards Lifesciences","title":"Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial","security_title":"NA","status":"RECRUITING","accession_number":"NCT04097145","excerpt":"[\"Tricuspid Regurgitation\",\"Tricuspid Valve Insufficiency\",\"Tricuspid Valve Disease\"]","importance":25},{"ts":"2026-05-08","kind":"sec.insider.f","reporter":"Zovighian Bernard J","title":"CEO","shares":5398,"price_per_share":82.76,"usd_value":446738,"security_title":"Common Stock","importance":15.44673848},{"ts":"2026-05-08","kind":"sec.insider.f","reporter":"Ullem Scott B.","title":"CVP, Chief Financial Officer","shares":1661,"price_per_share":82.76,"usd_value":137464,"security_title":"Common Stock","importance":15.13746436},{"ts":"2026-05-08","kind":"sec.insider.f","reporter":"Chopra Daveen","title":"CVP, TMTT & Surgical","shares":1141,"price_per_share":82.76,"usd_value":94429,"security_title":"Common Stock","importance":15.09442916},{"ts":"2026-05-08","kind":"sec.insider.f","reporter":"BOBO DONALD E JR","title":"CVP,Strategy/Corp Development","shares":1038,"price_per_share":82.76,"usd_value":85905,"security_title":"Common Stock","importance":15.08590488},{"ts":"2026-05-08","kind":"sec.insider.f","reporter":"Lippis Daniel J.","title":"CVP, TAVR","shares":450,"price_per_share":82.76,"usd_value":37242,"security_title":"Common Stock","importance":15.037241999999999},{"ts":"2026-05-08","kind":"sec.insider.f","reporter":"Dahl Andrew M.","title":"SVP, Corporate Controller","shares":289,"price_per_share":82.76,"usd_value":23918,"security_title":"Common Stock","importance":15.02391764},{"ts":"2026-05-08","kind":"sec.insider.f","reporter":"Markowitz Wayne","title":"CVP, JAPAC","shares":226,"price_per_share":82.76,"usd_value":18704,"security_title":"Common Stock","importance":15.01870376},{"ts":"2026-05-08","kind":"sec.insider.f","reporter":"Bruls Annette","title":"CVP, EMEACLA","shares":84,"price_per_share":82.76,"usd_value":6952,"security_title":"Common Stock","importance":15.00695184},{"ts":"2026-05-08","kind":"sec.insider.a","reporter":"Davis Leslie C.","title":null,"shares":3251,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-08","kind":"sec.insider.a","reporter":"Feinberg David T","title":null,"shares":3251,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-08","kind":"sec.insider.a","reporter":"GALLAHUE KIERAN","title":null,"shares":3251,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-08","kind":"sec.insider.a","reporter":"GALLAHUE KIERAN","title":null,"shares":1064,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-08","kind":"sec.insider.a","reporter":"STONE HEISZ LESLIE","title":null,"shares":3251,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-08","kind":"sec.insider.a","reporter":"LAVIOLETTE PAUL A","title":null,"shares":3251,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-08","kind":"sec.insider.a","reporter":"LORANGER STEVEN R","title":null,"shares":3251,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-08","kind":"sec.insider.a","reporter":"LORANGER STEVEN R","title":null,"shares":1064,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-08","kind":"sec.insider.a","reporter":"Sequeira Ramona","title":null,"shares":3251,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-08","kind":"sec.insider.a","reporter":"VALERIANI NICHOLAS J","title":null,"shares":5127,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-08","kind":"sec.insider.g","reporter":"Zovighian Bernard J","title":"CEO","shares":4222,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-08","kind":"sec.insider.g","reporter":"Zovighian Bernard J","title":"CEO","shares":4222,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-05-07","kind":"clinical.trial","reporter":"Edwards Lifesciences","title":"ProspeCtive, nOn-randoMized, MulticENter Clinical Evaluation of Edwards Pericardial Bioprostheses With a New Tissue Treatment Platform (COMMENCE)","security_title":"NA","status":"COMPLETED","accession_number":"NCT01757665","excerpt":"[\"Aortic Stenosis\",\"Mitral Stenosis\",\"Aortic Valve Insufficiency\",\"Mitral Valve Insufficiency\",\"Heart Failure\"]","importance":25},{"ts":"2026-05-07","kind":"sec.insider.f","reporter":"Zovighian Bernard J","title":"CEO","shares":4153,"price_per_share":83.2,"usd_value":345530,"security_title":"Common Stock","importance":15.3455296},{"ts":"2026-05-07","kind":"sec.insider.f","reporter":"Ullem Scott B.","title":"CVP, Chief Financial Officer","shares":1373,"price_per_share":83.2,"usd_value":114234,"security_title":"Common Stock","importance":15.1142336},{"ts":"2026-05-07","kind":"sec.insider.f","reporter":"BOBO DONALD E JR","title":"CVP,Strategy/Corp Development","shares":831,"price_per_share":83.2,"usd_value":69139,"security_title":"Common Stock","importance":15.0691392},{"ts":"2026-05-07","kind":"sec.insider.f","reporter":"Chopra Daveen","title":"CVP, TMTT & Surgical","shares":674,"price_per_share":83.2,"usd_value":56077,"security_title":"Common Stock","importance":15.0560768},{"ts":"2026-05-07","kind":"sec.insider.f","reporter":"Lippis Daniel J.","title":"CVP, TAVR","shares":309,"price_per_share":83.2,"usd_value":25709,"security_title":"Common Stock","importance":15.0257088},{"ts":"2026-05-07","kind":"sec.insider.f","reporter":"Markowitz Wayne","title":"CVP, JAPAC","shares":264,"price_per_share":83.2,"usd_value":21965,"security_title":"Common Stock","importance":15.0219648},{"ts":"2026-05-07","kind":"sec.insider.a","reporter":"Bruls Annette","title":"CVP, EMEACLA","shares":6650,"price_per_share":0,"usd_value":0,"security_title":"Common Stock","importance":15}]}